Reference priceJPY ¥770.00Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Lisraya |
|---|---|
| Manufacturer | Priovant Therapeutics |
| Prescription required | Yes |
Lisraya tablets 1 x 30mg(brepocitinib)
brepocitinib
Description
Lisraya tablets 1 x 30mg(brepocitinib) is a medicine catalog record in the MediPriceHub database. Active ingredient: brepocitinib. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Priovant Therapeutics. Therapeutic category: Medicine Library > Dermatology Medicines > Skin inflammation. Pack information: 30 / 30. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
LISRAYA is indicated for the treatment of dermatomyositis in adult patients. LISRAYA is a Janus kinase (JAK) and tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of dermatomyositis in adult patients. Limitations of Use LISRAYA is not recommended for use in combination with other JAK inhibitors, other TYK2 inhibitors, or biologic DMARDs.How to Use
Use brepocitinib under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: brepocitinib. Pack size: 30 / 30. Pack unit: bottle. Manufacturer: Priovant Therapeutics. Origin country: United States. Source category: Medicine Library > Dermatology Medicines > Skin inflammation. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。